FDA Expands HPV Primary Screening Options - Top_Thought_Leaders - MDSpire

FDA Expands HPV Primary Screening Options

Regulatory action broadens available approaches for cervical cancer screening in US clinical practice.

  • By

  • Kathryn Wighton

  • February 4, 2026

  • 2 min

Share

Top Thought Leaders in Oncology

Brief introduction explaining scope and methodology.

Original Source(s)

FDA Expands HPV Primary Screening Options

  • by Kathryn Wighton

  • February 4, 2026

Related Content

Discrimination of benign and malignant ovarian sex cord-stromal tumors through the analysis of clinical features, MR imaging, and MR-based radiomics

Bilateral ovarian masses, massive ascites, and prior appendectomy: must it be ovarian cancer? ——a case report of pseudomyxoma peritonei 24 years after appendectomy

Recurrent IDH-mutant astrocytoma WHO grade 4 diagnosed during pregnancy: case report with literature review